Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
-
SKL'D Redefines Skilled Trades and Supply Chain Staffing in Atlanta
-
CERo Therapeutics Holdings, Inc. Announces Sarah Cannon Research Institute at Colorado Blood Cancer Institute as Key Clinical Trial Site for its Phase 1 Clinical Trial of CER-1236 in Acute Myeloid Leu
-
Le Vian Unveils Exclusive Emerald Ombré™ Collection at Jared Jewelers
-
Volatus Aerospace Fulfills Demonstration Order with a G-20 Defense Organization
-
Havila Shipping ASA: Notice of Ordinary General Meeting 15.05.25
-
S&P Global agrees to acquire ORBCOMM’s Automatic Identification System business, strengthening its supply chain and maritime offerings
-
S&P Global agrees to acquire ORBCOMM’s Automatic Identification System business, strengthening its supply chain and maritime offerings
-
VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market
-
Karat Packaging to Report 2025 First Quarter Financial Results and Host Conference Call on Thursday, May 8, 2025
-
Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025
-
X4 Pharmaceuticals to Report First-Quarter 2025 Financial Results and Host Conference Call and Webcast on May 1, 2025
-
Entrepreneur and Renowned Poet Sekou Andrews to be the Keynote Speaker at Duck Creek Formation ’25
-
Entrepreneur and Renowned Poet Sekou Andrews to be the Keynote Speaker at Duck Creek Formation ’25
-
Stellantis and Factorial Energy Reach Key Milestone in Solid-State Battery Development
-
Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference
-
Stellantis and Factorial Energy Reach Key Milestone in Solid-State Battery Development
-
Integer Announces CEO Succession Plan
-
First Merchants Corporation Announces First Quarter 2025 Earnings Per Share
-
Northstrive Biosciences Announces Positive FDA Response Supporting A Submission of IND for a Phase 2 Clinical Trial for EL-22 in Combination with GLP-1 Receptor Agonist for Obesity Treatment
-
FTC Solar to Announce First Quarter 2025 Financial Results Thursday, May 1, 2025
-
Independent Bank Corporation Reports 2025 First Quarter Results
-
SpyGlass Pharma Presents 18-Month Data Demonstrating Compelling Visual Acuity Results with Their IOL-mounted Innovative Drug Delivery Platform
-
Global Uranium and Forum Energy Metals Announce the Completion of Drilling and Ground Geophysical Surveys on the Northwest Athabasca Project, Saskatchewan
-
Reviva to Present Late-Breaking Poster on the RECOVER Long-term Open Label Extension Trial for Brilaroxazine in Schizophrenia at the 2025 ASCP Annual Meeting
-
Autonomize AI Prior Authorization Copilot: Helping Patients Get Care Faster, Safer, and with Less Stress
-
X4 Pharmaceuticals Announces Reverse Stock Split
-
Integer Holdings Corporation Reports First Quarter 2025 Results
-
2025 Economic Outlook: Weaker Growth Expected as Tariffs, Uncertainty Complicate Business Climate
-
ClearScale Signs New Strategic Collaboration Agreement with AWS to Empower Small and Medium-Sized Businesses to Accelerate Value in the Cloud
-
Carpenter Technology Reports Third Quarter Fiscal Year 2025 Results
-
VoIP-Pal Files Second Amended Complaints in Federal Court and Serves Defendants
-
ORYZON Raises €30 Million in Capital Increase
-
FEC Sponsors Meta Crypto Oasis 2025 in Dubai — A Premier Web3 Event Set to Redefine Digital Engagement
-
CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Monday, April 28, 2025
-
Indicium Unveils IndiMesh, an AI-Enabled Software and Services Framework Created to Help Large Enterprises Build, Scale and Sustain AI and Data Solutions
-
Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025
-
Esperion Unveils Promising Research Supporting Lead Development Candidates for Primary Sclerosing Cholangitis (PSC) at R&D Day 2025
-
Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data
-
Snyk Achieves FedRAMP Moderate Authorization
-
Krystal Biotech to Present at Upcoming Scientific Conferences
-
BioAtla Announces Poster Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting
-
Microchip Unveils New High-Density Power Module for AI at the Edge Applications
-
Prebid.org Debuts New Analytics Dashboard, Prebid Insights
-
ASP Isotopes Inc. Announces Proposed Secondary Listing on the Johannesburg Stock Exchange
-
Voltera Expands National Footprint with EV Charging Facilities for Light-Duty Fleets in California, Texas, Arizona, and Florida
-
Intrado Upgrades Columbus, OH 911 Services with NG911 Multimedia and AI-based Text Translation
-
Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025
-
Rezolve Ai Smashes Past $50 Billion in GMV in Explosive start to 2025, Over 50 Major Enterprises Now Live and Scaling
-
Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas

